nach oben

Acta Neuropathologica

Erschienen in:

01.07.2008 | Original Paper

Detection of human cytomegalovirus in different histological types of gliomas

verfasst von: Michael E. Scheurer, Melissa L. Bondy, Kenneth D. Aldape, Thomas Albrecht, Randa El-Zein

Erschienen in: Acta Neuropathologica | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

The association between human cytomegalovirus (HCMV) infection and glioblastoma has been a source of debate in recent years because of conflicting laboratory reports concerning the presence of the virus in glioma tissue. HCMV is a ubiquitous herpesvirus that exhibits tropism for glial cells and has been shown to transform cells in vitro. Using sensitive immunohistochemical and in situ hybridization methods in 50 glioma samples, we detected HCMV antigen and DNA in 21/21 cases of glioblastoma, 9/12 cases of anaplastic gliomas and 14/17 cases of low-grade gliomas. Reactivity against the HCMV IE1 antigen (72 kDa) exhibited histology-specific patterns with more nuclear staining for anaplastic and low-grade gliomas, while GBMs showed nuclear and cytoplasmic staining that likely occurs with latent infection. Using IHC, the number of HCMV-positive cells in GBMs was 79% compared to 48% in lower grade tumors. Non-tumor areas of the tissue contained only four and 1% of HCMV-positive cells for GBMs and lower grade tumors, respectively. Hybridization to HCMV DNA in infected cells corresponded to patterns of immunoreactivity. Our findings support previous reports of the presence of HCMV infection in glioma tissues and advocate optimization of laboratory methods for the detection of active HCMV infections. This will allow for detection of low-level latent infections that may play an important role in the initiation and/or promotion of malignant gliomas.

Albrecht T, Boldogh I, Fons M, Lee CH, AbuBakar S, Russell JM, Au WW (1989) Cell-activation responses to cytomegalovirus infection relationship to the phasing of CMV replication and to the induction of cellular damage. Subcell Biochem 15:157–202PubMed

Albrecht T, Fons MP, Deng CZ, Boldogh I (1997) Increased frequency of specific locus mutation following human cytomegalovirus infection. Virology 230:48–61PubMedCrossRef

Albrecht T, Deng CZ, Abdel-Rahman SZ, Fons M, Cinciripini P, El Zein RA (2004) Differential mutagen sensitivity of peripheral blood lymphocytes from smokers and nonsmokers: effect of human cytomegalovirus infection. Environ Mol Mutagen 43:169–178PubMedCrossRef

Arbustini E, Morbini P, Grasso M, Diegoli M, Fasani R, Porcu E, Banchieri N, Perfetti V, Pederzolli C, Grossi P, Dalla Gasperina D, Martinelli L, Paulli M, Ernst M, Plachter B, Vigano M, Solcia E (1996) Human cytomegalovirus early infection, acute rejection, and major histocompatibility class II expression in transplanted lung. Molecular, immunocytochemical, and histopathologic investigations. Transplantation 61:418–427PubMedCrossRef

Bagasra O, Hansen JA (ed) (2006) In situ PCR techniques. Wiley, New York

Bondy ML,Wrensch MR (1996) Epidemiology of primary malignant brain tumours Baillieres. Clin Neurol 5:251–270

Brenner AV, Linet MS, Selker RG, Shapiro WR, Black PM, Fine HA, Inskip PD (2003) Polio vaccination and risk of brain tumors in adults: no apparent association. Cancer Epidemiol Biomarkers Prev 12:177–178PubMed

Bresnahan WA, Boldogh I, Thompson EA, Albrecht T (1996) Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 224:150–160PubMedCrossRef

Britt WJ,Mach M (1996) Human cytomegalovirus glycoproteins. Intervirology 39:401–412PubMed

10.

Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347–3350PubMed

11.

Docke WD, Kiessling C, Worm M, Friedrich M, Pruss A, Weitz M, Prosch S, Kern F, Volk HD, Sterry W, Asadullah K (2003) Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis. Br J Dermatol 148:954–963PubMedCrossRef

12.

Doniger J, Muralidhar S, Rosenthal LJ (1999) Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate. Clin Microbiol Rev 12:367–382PubMed

13.

Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326:663–667PubMedCrossRef

14.

Hadfield MG, Murray BK, Thomson TA, Young HF (1984) Herpesvirus type 1 serum antibodies and brain tumors in humans. Clin Neuropathol 3:68–71PubMed

15.

Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, Cobbs CS (2002) Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360:1557–1563PubMedCrossRef

16.

Holm R (2005) In situ hybridization methods to study microbial populations and their interactions with human host cells. Methods Microbiol 34:1–25CrossRef

17.

Howley PM, Ganem D, Kieff E (ed) (2001) DNA Viruses. Lippincott Williams and Wilkins, Philadelphia

18.

Huang ES, Roche JK (1978) Cytomegalovirus D.N.A. and adenocarcinoma of the colon: Evidence for latent viral infection. Lancet 1:957–960PubMedCrossRef

19.

Huang G, Yan Q, Wang Z, Chen X, Zhang X, Guo Y, Li JJ (2002) Human cytomegalovirus in neoplastic cells of Epstein–Barr virus negative Hodgkin’s disease. Int J Oncol 21:31–36PubMed

20.

Kalejta RF, Shenk T (2002) Manipulation of the cell cycle by human cytomegalovirus. Front Biosci 7:d295–d306PubMedCrossRef

21.

Khalili K, Krynska B, Del Valle L, Katsetos CD, Croul S (1999) Medulloblastomas and the human neurotropic polyomavirus. JC Virus Lancet 353:1152–1153CrossRef

22.

Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G (1998) High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 26:1076–1082PubMedCrossRef

23.

Lau SK, Chen YY, Chen WG, Diamond DJ, Mamelak AN, Zaia JA, Weiss LM (2005) Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 18:838–843PubMedCrossRef

24.

Lokensgard JR, Cheeran MC, Gekker G, Hu S, Chao CC, Peterson PK (1999) Human cytomegalovirus replication and modulation of apoptosis in astrocytes. J Hum Virol 2:91–101PubMed

25.

Martin JD, King DM, Slauch JM, Frisque RJ (1985) Differences in regulatory sequences of naturally occurring JC virus variants. J Virol 53:306–311PubMed

26.

Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 1:10–18CrossRef

27.

Ohagen A, Gibaja V, Horrigan J, Lunderville D, Jayarama V, Marcello J, Chapman J, Lazo A (2004) Induction of latent human cytomegalovirus by conventional gamma irradiation and prevention by treatment with INACTINE PEN110. Vox Sang 87:1–9PubMedCrossRef

28.

Onorato IM, Morens DM, Martone WJ, Stansfield SK (1985) Epidemiology of cytomegaloviral infections: recommendations for prevention and control. Rev Infect Dis 7:479–497PubMed

29.

Piña-Oviedo S, De León-Bojorge B, Cuesta-Mejías T, White MK, Ortiz-Hidalgo C, Khalili K, Del Valle L (2006) Glioblastoma multiforme with small cell neuronal-like component: association with human neurotropic JC virus. Acta Neuropathol 111(4):388–96PubMedCrossRef

30.

Poltermann S, Schlehofer B, Steindorf K, Schnitzler P, Geletneky K, Schlehofer JR (2006) Lack of association of herpesviruses with brain tumors. J Neurovirol 12:90–99PubMedCrossRef

31.

Rencic A, Gordon J, Otte J, Curtis M, Kovatich A, Zoltick P, Khalili K, Andrews D (1996) Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma. Proc Natl Acad Sci USA 93:7352–7357PubMedCrossRef

32.

Sabatier J, Uro-Coste E, Benouaich A, Boetto S, Gigaud M, Tremoulet M, Delisle MB, Galateau-Salle F, Brousset P (2005) Immunodetection of SV40 large T antigen in human central nervous system tumours. J Clin Pathol 58:429–431PubMedCrossRef

33.

Sabatier J, Uro-Coste E, Pommepuy I, Labrousse F, Allart S, Tremoulet M, Delisle MB, Brousset P (2005) Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 92:747–750PubMedCrossRef

34.

Samanta M, Harkins L, Klemm K, Britt WJ, Cobbs CS (2003) High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170:998–1002PubMedCrossRef

35.

Sanford EJ, Geder L, Laychock A, Rohner TJ, Rapp F (1977) Evidence for the association of cytomegalovirus with carcinoma of the prostate. J Urol 118:789–792PubMed

36.

Scheurer ME, Lopez MS, Chrisman K, Albrecht T, Bondy ML, El-Zein R (2007) Effects of Human cytomegalovirus infection on radiation-induced cytogenetic damage in peripheral blood lymphocytes from a glioma case-control study. In: American Association of Cancer Research Annual meeting

37.

Shen Y, Zhu H, Shenk T (1997) Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate “hit-and-run” oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci USA 94:3341–3345PubMedCrossRef

38.

Soderberg-Naucler C (2006) Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 259:219–246PubMedCrossRef

39.

Weller TH (1971) The cytomegaloviruses: ubiquitous agents with protean clinical manifestations II. N Engl J Med 285:267–274PubMedCrossRef

40.

Wrensch M, Weinberg A, Wiencke J, Masters H, Miike R, Barger G, Lee M (1997) Does prior infection with varicella-zoster virus influence risk of adult glioma? Am J Epidemiol 145:594–597PubMed

41.

Wrensch M, Weinberg A, Wiencke J, Miike R, Barger G, Kelsey K (2001) Prevalence of antibodies to four herpesviruses among adults with glioma and controls. Am J Epidemiol 154:161–165PubMedCrossRef

Titel: Detection of human cytomegalovirus in different histological types of gliomas
verfasst von: Michael E. Scheurer
Melissa L. Bondy
Kenneth D. Aldape
Thomas Albrecht
Randa El-Zein
Publikationsdatum: 01.07.2008
Verlag: Springer-Verlag
Erschienen in: Acta Neuropathologica / Ausgabe 1/2008
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-008-0359-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2008

Copy number alterations of the polycomb gene BMI1 in gliomas

A critical reappraisal of current staging of Lewy-related pathology in human brain

Glial clusters and perineuronal glial satellitosis in the basal ganglia of neurofibromatosis type 1

Glioma-like proliferation within tissues excised as tubers in patients with tuberous sclerosis complex

Co-localization of tau and α-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies